Back to Search
LUCY PATTERSON, PHARMD
PHARMD
Pharmacist
NPI: 1780986620Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
20061(NC)0202208373(VA)
Research & Publications (20)
Replicating adenovirus HIV/SIV recombinant priming alone or in combination with a gp140 protein boost results in significant control of viremia following a SHIV89.6P challenge in Mamu-A*01 negative rhesus macaques.
PMID 18252262·Virology·2008
7-preclinical
Replicating adenovirus vector prime/protein boost strategies for HIV vaccine development.
PMID 18694354·Expert Opin Biol Ther·2008
6-review
Measuring children and monitoring obesity: surveys of English Primary Care Trusts 2004-06.
PMID 17074777·J Public Health (Oxf)·2006
8-other
Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting.
PMID 14963117·J Virol·2004
7-preclinical
Potent, persistent induction and modulation of cellular immune responses in rhesus macaques primed with Ad5hr-simian immunodeficiency virus (SIV) env/rev, gag, and/or nef vaccines and boosted with SIV gp120.
PMID 12885879·J Virol·2003
7-preclinical
Potent, persistent cellular immune responses elicited by sequential immunization of rhesus macaques with Ad5 host range mutant recombinants encoding SIV Rev and SIV Nef.
PMID 12396605·DNA Cell Biol·2002
7-preclinical
Insertion of HIV-1 genes into Ad4DeltaE3 vector abrogates increased pathogenesis in cotton rats due to E3 deletion.
PMID 11878913·Virology·2002
7-preclinical
Bioreductively activated antitumor N-oxides: the case of AQ4N, a unique approach to hypoxia-activated cancer chemotherapy.
PMID 12214668·Drug Metab Rev·2002
6-review
Hoxa11 and Hoxd11 regulate branching morphogenesis of the ureteric bud in the developing kidney.
PMID 11493536·Development·2001
7-preclinical
A conformational C4 peptide polymer vaccine coupled with live recombinant vector priming is immunogenic but does not protect against rectal SIV challenge.
PMID 11429125·AIDS Res Hum Retroviruses·2001
7-preclinical
Enhancement of chemotherapy and radiotherapy of murine tumours by AQ4N, a bioreductively activated anti-tumour agent.
PMID 10864207·Br J Cancer·2000
7-preclinical
Cross-protection in NYVAC-HIV-1-immunized/HIV-2-challenged but not in NYVAC-HIV-2-immunized/SHIV-challenged rhesus macaques.
PMID 11101054·AIDS·2000
7-preclinical
Analyses of school commuting data for exposure modeling purposes.
PMID 19240760·J Expo Sci Environ Epidemiol·2010
8-other
Impact of a school-based influenza immunization program on disease burden: comparison of two Tennessee counties.
PMID 19428881·Vaccine·2009
4-observational
Blunt pancreatoduodenal injury: a multicenter study of the Research Consortium of New England Centers for Trauma (ReCONECT).
PMID 19451482·Arch Surg·2009
4-observational
Function and antagonism of beta3 integrins in the development of cancer therapy.
PMID 19519320·Curr Cancer Drug Targets·2009
6-review
All you have to do is call; a pilot study to improve the outcomes of patients with coronary artery disease.
PMID 19427576·Appl Nurs Res·2009
2-rct
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1802 N POINTE DR
DURHAM, NC 27705 - Phone
- (919) 220-6766
Quick Facts
- NPI
- 1780986620
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile